COMMUNIQUÉS West-GlobeNewswire

Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year
04/11/2025
C ompany Achieves Third Consecutive Quarter of Revenue Growth Revenue Increase of Approximately 32% Sequentially and 28% Year-Over-Year Driven by New Customer Accounts and Strong Cartridge and Reader Sales Cartridge and [...]
Sofwave Medical Reports Third Quarter 2025 Financial Results and Business Highlights
04/11/2025
— Record quarterly revenue in third quarter of $21.1M, +56% year-over-year growth; IFRS gross margin of 73.7% — Third quarter pulse recurring revenue of $8.3M, +55% year-over-year growth — First nine months revenue of $ [...]
NeurAxis to Host Third Quarter 2025 Results and Business Update Call on Tuesday, November 11, 2025
04/11/2025
Financial results to be released before market open; Conference call to be conducted at 9:00 a.m. Eastern Time CARMEL, Ind., Nov. 04, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American [...]
CVRx to Present at the Jefferies Global Healthcare Conference in London
04/11/2025
MINNEAPOLIS, Nov. 04, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions [...]
Artelo Biosciences Announces Publication of Peer-Reviewed Article on Role of Fatty Acid Binding Proteins in Cancer
04/11/2025
Highlights Broad Development Potential of Proprietary Portfolio Targeting FABPs SOLANA BEACH, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company [...]
TELA Bio to Announce Third Quarter 2025 Financial Results
04/11/2025
MALVERN, Pa., Nov. 04, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today [...]
InStride Health Announces Key Leadership Additions, Promotions to Enhance Payer Engagement, Technical Enablement, and Clinical Operations
04/11/2025
With new and elevated leaders, InStride is poised to scale its care model while maintaining its differentiated specialty care BOSTON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- InStride Health , a leading insurance-based [...]
Aligos Therapeutics to Present at Upcoming Investor Conferences
04/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies [...]
24/7 Market News- Kraig Labs’ Spider Silk Breakthrough Poised to Rival Nylon’s 1939 Revolution
04/11/2025
The Dawn of a New Fiber Era DENVER, Nov. 04, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of financial market news and information, reports that in 1939, [...]
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections
04/11/2025
New FDA feedback confirms clinical pathway for fixed multi-phage cocktail BX011, expanding development into diabetic foot infections (DFI) and unlocking a major commercial opportunity NESS ZIONA, Israel, Nov. 04, 2025 ( [...]
Tango Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights
04/11/2025
– Data update from vopimetostat (TNG462) showed 2L MTAP-del pancreatic cancer median progression free survival (mPFS) 7.2 months– – Combination studies with RAS(ON) inhibitors ongoing, data anticipated 2026 – – 49% ORR [...]
RESET™ Clinical Trial Demonstrates Superior Pain Relief with SPRINT® PNS Compared to Standard Interventional Management for Chronic Low Back Pain
04/11/2025
The study met its Primary Endpoint of pain relief and showed that SPRINT PNS delivered significant improvements in patient-centric secondary endpoints CLEVELAND, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Published in the [...]
Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies
04/11/2025
VANCOUVER, British Columbia, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Optigo Biotherapeutics (“ Optigo ”) , an ophthalmology company pioneering next-gen treatments for retinal diseases, today announced that Dr. Andreas [...]
WORK Medical Technology Group LTD’s Subsidiary Retains a US$114,000 Service Contract from GemPharmatech Corporation
04/11/2025
Hangzhou, China, Nov. 04, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) (“WORK Medical” or the “Company”), a supplier of medical devices in China, through its subsidiary, Work (Hangzhou) [...]
Marius Pharmaceuticals Leads Effort to Redefine Women’s Health Through Testosterone Research
04/11/2025
All-female advisory board to guide Marius in addressing the unmet need for safe, effective testosterone therapies for women RALEIGH, N.C., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, Inc. , today announced [...]
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
04/11/2025
CTX-10726 demonstrated potent, simultaneous inhibition of tumor angiogenesis and PD-1-mediated immune suppression, and eliminated tumors in multiple preclinical studies. In vivo, CTX-10726 outperformed select [...]
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
04/11/2025
Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., FMedSci, Candel’s President and CEO, will present the phase 3 clinical trial of [...]
Anathapindika Health Increases Stock Ahead of Expected U.S. Surge
04/11/2025
The Buddhist-Inspired Natural Health and Wellness Brand Has Increased Its Production in the Midst of a U.S. Rollout Fort Lauderdale, FL, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The United States has the biggest health and [...]
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
04/11/2025
CR-001 Demonstrated Cooperative Pharmacology and Robust Anti-Tumor Activity IND Submission for CR-001 On Track for Fourth Quarter of 2025 to Support Initiation of Global Phase 1 Trial in Patients with Solid Tumors [...]

Pages